In a systematic review and meta-analysis (37 studies, 12,629 people with SARS-CoV-2), pooled seroprevalence of anti-IFNα and/or anti-IFNω auto-antibodies was 14% (neutralising 12%) vs <1% anti-IFNα in healthy controls; heterogeneity was high and other infections lacked data.
Meta-analysisn = 12,629
Hill et al. Systematic Review and Meta-analysis of Anti-interferon Auto-antibodies in Infectious Diseases